Fut, nem toboroz2. fázis
RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
A legfontosabb adatok
- Ki végzi
- Altimmune, Inc.
- Hol
- Atlanta, Bastrop, Bradenton, Brownsville, Dallas, Doral, Edinburg, Fort Myers, Fresno, Houston, Indianapolis, La Jolla, Las Vegas, Louisville, Manhasset, Marrero, Miami, Miami Lakes, Naples, New York, North Little Rock, Orlando, Pasadena, Peoria, San Antonio, Seattle, St Louis, Syracuse, Tucson, Waco, West Monroe, Westlake és Wilmington (Egyesült Államok)Mind a 33 helyszín megnézéseMég 1 másik országban, 1 helyszínen
- Azonosító
- Állapot
- Fut, nem toboroz
- Fázis
- 2. fázis
- Résztvevők
- 121 fő vett részt
- Kezdés
- 2025. jún. 16.
- Várható befejezés
- 2027. szept. 30.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Pemvidutide
- Placebo
- A regiszteradat frissítve
- 2026. augusztus 17.
Ki vehet részt
- Életkor
- 18 év – 75 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 10 feltétel megnézéseKevesebb
Ki vehet részt
- Male or female ages 18 to 75 years, inclusive
- Overweight or obesity, defined as BMI ≥ 25 kg/m2
- History of alcohol misuse for the prior 3 years, with an alcohol intake ≥ 50 grams per day for males and ≥ 40 grams per day for females on average in the past year
- Evidence of recent alcohol use, defined as PEth level ≥ 35 ng/mL at screening
- Liver stiffness of 10.0-24.9 kPa by VCTE, inclusive
Ki nem vehet részt
- Presence of clinically significant alcohol withdrawal symptoms, defined as CIWA-Ar score ≥ 10 at screening and/or prior to randomization
- History and/or current diagnosis of schizophrenia, bipolar disorder, psychotic disorder, or another severe psychiatric disorder, unless documented as well-controlled by the Investigator for at least 6 months prior to screening and cleared by the Medical Monitor
- History of hospitalization for alcohol withdrawal within the past year
- History of seizures related to alcohol within the past year
- Attempted suicide and/or serious suicidal intention or plan in the past 10 years
Helyszínek itt: Egyesült Államok
Még 1 másik országban, 1 helyszínen
- Atlanta, GeorgiaHospital not named in the registry
- Bastrop, LouisianaHospital not named in the registry
- Bradenton, FloridaHospital not named in the registry
- Brownsville, TexasHospital not named in the registry
- Dallas, TexasHospital not named in the registry
- Doral, FloridaHospital not named in the registry
- Edinburg, TexasHospital not named in the registry
- Fort Myers, FloridaHospital not named in the registry
- Fresno, CaliforniaHospital not named in the registry
- Houston, TexasHospital not named in the registry
- Indianapolis, IndianaHospital not named in the registry
- La Jolla, CaliforniaHospital not named in the registry
- Las Vegas, NevadaHospital not named in the registry
- Louisville, KentuckyHospital not named in the registry
- Manhasset, New YorkHospital not named in the registry
- Marrero, LouisianaHospital not named in the registry
- Miami, FloridaHospital not named in the registry
- Miami Lakes, FloridaHospital not named in the registry
- Naples, FloridaHospital not named in the registry
- New YorkHospital not named in the registry
- North Little Rock, ArkansasHospital not named in the registry
- Orlando, FloridaHospital not named in the registry
- Pasadena, CaliforniaHospital not named in the registry
- Peoria, ArizonaHospital not named in the registry
- San Antonio, TexasHospital not named in the registry
- Seattle, WashingtonHospital not named in the registry
- St Louis, MissouriHospital not named in the registry
- Syracuse, New YorkHospital not named in the registry
- Tucson, ArizonaHospital not named in the registry
- Waco, TexasHospital not named in the registry
- West Monroe, LouisianaHospital not named in the registry
- Westlake, OhioHospital not named in the registry
- Wilmington, North CarolinaHospital not named in the registry
A vizsgálatról
Mit akar kideríteni a vizsgálat
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD.
A vizsgálat 2 csoportja
- Pemvidutide 2.4 mgMár használt kezelés, összehasonlításként
Kezelés: Pemvidutide
- PlaceboPlacebo, összehasonlításként
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- RESTORE TRIAL: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
- A regiszteradat frissítve
- 2026. augusztus 17.